‘A sigh of relief’: New malaria drug succeeds in clinical trial as existing treatments falter

Ganaplacide, developed by Novartis, eases worries about drug resistance-but hard choices loom on how to use it.

Authors

Institutions

Publication Details

Journal
Science
Published
2025-11-20
DOI
https://doi.org/10.1126/science.aee0352
Primary Topic
Malaria Research and Control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

‘A sigh of relief’: New malaria drug succeeds in clinical trial as existing treatments falter

Kai Kupferschmidt
Science
Malaria Research and Control
article

‘A sigh of relief’: New malaria drug succeeds in clinical trial as existing treatments falter

Kai Kupferschmidt
article en

Abstract

Ganaplacide, developed by Novartis, eases worries about drug resistance-but hard choices loom on how to use it.

ScienceVol. 390(6775)
Toronto Public Health (CA)
Openalex Percentile: Top 54%
Malaria Research and Control
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

‘A sigh of relief’: New malaria drug succeeds in clinical trial as existing treatments falter — Kai Kupferschmidt · Science (2025) | TGRS Research Map | TGRS